Thread by @sheislaurenlee

🚨 Is Bobby Kennedy about to BANKRUPT Big Pharma?

Thimerosal (mercury) was the test ground for a billion-dollar battle:

Aluminum.

If the data confirms what scientists suspect, it could END the vaccine-for-profit model forever.

The collapse will be glorious…

And it all starts September 2025.

THREAD 🧵

First, you’ll want to bookmark this thread for future reference. 📌

This is a numbers-heavy thread, so bear with me.

And according to those numbers, once aluminum is linked to autism, the cost to Pharma profits will threaten the entire industry. 👇

This week gave us a glimpse of the future:

RFK Jr. just forced mercury out of flu shots, costing Pharma millions.

The shift to mercury-free, single-dose vials is no small feat.

It demands higher production costs, R&D investment, and in some cases, facility upgrades.

Even for just flu vaccines, that’s an estimated loss of $3.75M to $18.75M annually for a manufacturer like GSK, varying depending on size.

Here’s what no one seems to be reporting:

Mercury was just step one.

Now, RFK Jr. has his sights on an ingredient that is far more prevalent in the industry…. And would make a much bigger dent in Pharma’s pocket:

Aluminum.

In an interview at the National Governors Meeting this week, RFK Jr. made it clear that vaccinated children are 30 times more likely to have injuries than the unvaccinated.

“We need to look into aluminum; and look into it NOW.”

But if RFK Jr.’s prior statements are true, hundreds of scientists are already quietly investigating aluminum.

According to him, we’ll have results within two months.

Post-September, Big Pharma is at risk for a catastrophic re-organization… and maybe even collapse.

If you’re a Pharma rep looking at these numbers, you’re terrified.

Let’s break it down 👇

But first, let’s make sure we don’t lose each other in the algorithm forever.

I cover MAHA, medical freedom, and all things sacred.

If that interests you, shoot me a follow.

—> @sheislaurenlee 🛎️

Back to the thread:

In the U.S., infants receive approximately 4.4 mg of aluminum from vaccines in the first six months.

The schedule is FULL of aluminum, isn’t a little fix.

(Hep A, Hep B, DTaP, Tdap, HPV Pneumococcal just to name a few .)

By 18 months, total exposure to aluminum can range from 3,020–4,875 mcg, depending on the brand.

This is widespread misuse and a severe cost would be incurred to amend it.

No wonder they’re freaking out.

Either Pharma would have to develop new adjuvants or they would have to reformulate the vaccines to be effective without adjuvants, both of which involve significant research and development (R&D) and clinical trial costs. 👇👇

One single new vaccine or adjuvant can cost $500 million to $2 billion to develop, with clinical trials alone costing $100 million to $500 million per vaccine.

These costs would apply to each vaccine requiring a new adjuvant.

For reference, Heplisav-B and Shingrix required similar investments.

Even without new adjuvants, reformulating the vaccines would be a substantial cost.

Reformulation would require new clinical trials to prove safety and efficacy, costing $50 million to $300 million per vaccine based on past developments.

Assuming the need to redo 12 of the childhood vaccines on the schedule (there may be more), the cost of reformulation with and without adjuvants will land between $10 billion to $24 billion.

And that’s only the beginning.
👇

Retooling production facilities, including new equipment, quality control systems, and staff training could cost the industry $100 million to $500 million per corporation.

I’ll be publishing a full cost analysis and deep-dive on the impact of an aluminum ban tomorrow, complete with all sources and industry comparisons.

There, you can review the evidence and the numbers for yourself.

Sign up HERE to get it free in your inbox:

🤝sheislaurenlee.com

What’s really crazy is even after all this spending, regulatory approval isn’t automatic.

Each reformulated vaccine must go through a new approval process via HHS.

The historical cost for this is between $10M–$50M per vaccine. (See: Gardasil, Vaxelis, Fluad.)

That’s up to another $600M.

We haven’t even factored in: supply chain disruptions, global compliance, re-training for healthcare providers, public backlash, market withdrawal timelines, and more.

In total: Pharma could be facing an initial loss of $30B+.

Significantly higher than the $3-10 million estimate for removing thimerosal, due to aluminum’s critical role as an adjuvant in a wide range of vaccines.

Aluminum is central to the vaccine business model. Without it, their entire platform collapses.

They admit it.

We’ve all seen the clip:

Yep, the famous “tidal wave of lawsuits.”

$30 billion is the starting point of Pharma’s post-aluminum loss.

Before anyone sues them for injuries caused by the ingredient.

Theoretically, there is no cap to how much profits could fall once they lose immunity.

It’s going to be brutal.

But that’s another post for another time.

Even if no lawsuits ever happen, the reformulations ALONE are enough to put Pharma in the red…

Regulation would consume 1–6 years of vaccine profits or 1–2 years of total profits for major manufacturers, a major financial burden.

And ongoing costs could erode an unsustainable 50–100% of vaccine profits annually, threatening the viability of vaccine production ALTOGETHER. 👇

We are on the precipice of great change.

But all of this relies on one thing:

HHS staying on-schedule with their September deadline.

This could be the start of it all.

If you support the Secretary, show it by sharing this thread!

Let’s send a strong signal that MAHA stands behind Bobby Kennedy.

No matter the shakeup.

👏👇